Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Senseonics Holdings (SENS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 481,326
  • Shares Outstanding, K 176,958
  • Annual Sales, $ 18,910 K
  • Annual Income, $ -93,970 K
  • 60-Month Beta 1.32
  • Price/Sales 24.89
  • Price/Cash Flow N/A
  • Price/Book 6.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.14
  • Number of Estimates 4
  • High Estimate -0.06
  • Low Estimate -0.19
  • Prior Year -0.16
  • Growth Rate Est. (year over year) +12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.51 +9.56%
on 03/18/19
3.37 -18.40%
on 03/04/19
+0.07 (+2.61%)
since 02/21/19
3-Month
2.15 +27.91%
on 02/05/19
3.37 -18.40%
on 03/04/19
+0.15 (+5.77%)
since 12/21/18
52-Week
2.15 +27.91%
on 02/05/19
5.29 -48.02%
on 06/22/18
-0.31 (-10.13%)
since 03/21/18

Most Recent Stories

More News
Is the Options Market Predicting a Spike in Senseonics Holdings (SENS) Stock?

Investors need to pay close attention to Senseonics Holdings (SENS) stock based on the movements in the options market lately.

SENS : 2.74 (+0.74%)
Senseonics Holdings (SENS) Reports Q4 Loss, Lags Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of 73.33% and -8.75%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

SENS : 2.74 (+0.74%)
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.74 (+0.74%)
Senseonics Announces Appointment of Francine R. Kaufman, M.D. as Chief Medical Officer

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.74 (+0.74%)
Senseonics Eversense(R) CGM Launches Integration with Glooko

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.74 (+0.74%)
Senseonics to Participate in the Cowen Health Care Conference

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.74 (+0.74%)
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for March 12, 2019 at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.74 (+0.74%)
Senseonics Announces Extension of Distribution Agreement with Roche Diabetes Care

--Conference Call Monday, February 4, 2019 at 8:00 a.m. ET

SENS : 2.74 (+0.74%)
Detailed Research: Economic Perspectives on Inovalon, Merit Medical, Senseonics, Ocular Therapeutix, The Hartford Financial Services Group, and Synopsys -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Inovalon Holdings, Inc....

SENS : 2.74 (+0.74%)
MMSI : 60.33 (+1.04%)
HIG : 48.89 (+1.37%)
SNPS : 111.18 (+1.75%)
INOV : 12.65 (+1.52%)
OCUL : 4.25 (+2.16%)
Senseonics Appoints Jon D. Isaacson as Chief Financial Officer

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.74 (+0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade SENS with:

Business Summary

Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.

See More

Key Turning Points

2nd Resistance Point 2.84
1st Resistance Point 2.78
Last Price 2.74
1st Support Level 2.66
2nd Support Level 2.60

See More

52-Week High 5.29
Fibonacci 61.8% 4.09
Fibonacci 50% 3.72
Fibonacci 38.2% 3.35
Last Price 2.74
52-Week Low 2.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar